Asia-Pacific Newborn Screening Market to 2032
Overview
The Asia-Pacific Newborn Screening Market is expected to reach a 911.01 USD Billion by 2032 and is projected to grow at a CAGR of 14.70% from 2025 to 2032.
Revenue, 2024 (USD Billion)
388.16
Forecast, 2032 (USD Billion)
911.01
CAGR, 2024 - 2032
14.70%
Report Coverage
Asia-Pacific
Asia-Pacific Newborn Screening Market 2018-2032 USD Billion
Asia-Pacific Newborn Screening Market , Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 388.16 USD Billion
- Projected Market Size (2032): 911.01 USD Billion
- CAGR (2025-2032): 14.70%
Key Findings of Asia-Pacific Newborn Screening Market
- The Asia-Pacific Newborn Screening Market was valued at 388.16 USD Billion in 2024.
- The Asia-Pacific Newborn Screening Market is likely to grow at a CAGR of 14.70% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Hospital in End User Segment accounted for the largest share of the market with a revenue of 279.77 USD Billion
- The fastest growing segment Hearing Screen Test in Test Type Segment grew Fastest with a CAGR of 15.67% during the forecast period from 2024 to 2032.
Asia-Pacific Newborn Screening Market Scope
Asia-Pacific Newborn Screening Market Segmentation & Scope
Technology
- DNA-Based Assays
- Electrophoresis
- Immunoassays and Enzymatic Assays
- Pulse Oximetry Screening Technology
- Hearing Screen Technology
- Tandem Mass Spectrometry
Product Type
- Reagents and Assay Kits
- Instruments
Test Type
- Critical Congenital Heart Diseases (CCHD) Test
- Hearing Screen Test
- Dried Blood Spot Test
End User
- Clinics
- Pediatric Clinics
- Hospital
Disease Type
- Others
- Maple Syrup Urine Disease
- Phenylketonuria (PKU)
- Cystic Fibrosis (CF)
- Sickle Cell Disease
- Newborn Hearing Loss
- Critical Congenital Heart Diseases
Asia-Pacific Newborn Screening Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 388.16 USD Billion |
| Market Value in 2032 | 911.01 USD Billion |
| CAGR (2025-2032) | 14.70% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Technology,Product Type,Test Type,End User,Disease Type |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 388.16 USD Billion in 2024
- Key Country: Japan, leading in terms of revenue with value of 84.91 USD Billion in 2024.
Segments and Scope
-
Asia-Pacific Newborn Screening Market to 2032, By Technology
- Tandem Mass Spectrometry is the largest segment in Asia-Pacific Newborn Screening Market to 2032 with a revenue of 108.69 USD Billion in the year 2024.
- Tandem Mass Spectrometry is the Fastest growing segment in Asia-Pacific Newborn Screening Market to 2032 with a Growth rate of 15.56 % in forecast period 2025-2032.
-
Asia-Pacific Newborn Screening Market to 2032, By Product Type
- Instruments is the largest segment in Asia-Pacific Newborn Screening Market to 2032 with a revenue of 266.45 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in Asia-Pacific Newborn Screening Market to 2032 with a Growth rate of 14.99 % in forecast period 2025-2032.
-
Asia-Pacific Newborn Screening Market to 2032, By Test Type
- Dried Blood Spot Test is the largest segment in Asia-Pacific Newborn Screening Market to 2032 with a revenue of 169.32 USD Billion in the year 2024.
- Hearing Screen Test is the Fastest growing segment in Asia-Pacific Newborn Screening Market to 2032 with a Growth rate of 14.26 % in forecast period 2025-2032.
-
Asia-Pacific Newborn Screening Market to 2032, By End User
- Hospital is the largest segment in Asia-Pacific Newborn Screening Market to 2032 with a revenue of 279.77 USD Billion in the year 2024.
- Hospital is the Fastest growing segment in Asia-Pacific Newborn Screening Market to 2032 with a Growth rate of 14.99 % in forecast period 2025-2032.
-
Asia-Pacific Newborn Screening Market to 2032, By Disease Type
- Critical Congenital Heart Diseases is the largest segment in Asia-Pacific Newborn Screening Market to 2032 with a revenue of 255.86 USD Billion in the year 2024.
- Critical Congenital Heart Diseases is the Fastest growing segment in Asia-Pacific Newborn Screening Market to 2032 with a Growth rate of 15.07 % in forecast period 2025-2032.
Asia-Pacific Newborn Screening Market Company Share Analysis
Asia-Pacific Newborn Screening Market Geographical Sales Distribution, 2018-2032 USD Billion
Asia-Pacific Newborn Screening Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Newborn Screening Market is segmented based on Segmentation Technology,Product Type,Test Type,End User,Disease Type.
Asia-Pacific Newborn Screening Market was valued at USD 388.16(Revenue in USD Billion) in 2022.
Asia-Pacific Newborn Screening Market is projected to grow at a CAGR of 14.70% during the forecast period of 2024 to 2032.
The Hospital segment is expected to dominate the Asia-Pacific Newborn Screening Market , holding a largest market share of 279.77 USD Billion in 2024
Asia-Pacific Newborn Screening Market Scope
Asia-Pacific Newborn Screening Market Segmentation & Scope
Technology
- DNA-Based Assays
- Electrophoresis
- Immunoassays and Enzymatic Assays
- Pulse Oximetry Screening Technology
- Hearing Screen Technology
- Tandem Mass Spectrometry
Product Type
- Reagents and Assay Kits
- Instruments
Test Type
- Critical Congenital Heart Diseases (CCHD) Test
- Hearing Screen Test
- Dried Blood Spot Test
End User
- Clinics
- Pediatric Clinics
- Hospital
Disease Type
- Others
- Maple Syrup Urine Disease
- Phenylketonuria (PKU)
- Cystic Fibrosis (CF)
- Sickle Cell Disease
- Newborn Hearing Loss
- Critical Congenital Heart Diseases
Frequently Asked Questions
The Asia-Pacific Newborn Screening Market is segmented based on Segmentation Technology,Product Type,Test Type,End User,Disease Type.
Asia-Pacific Newborn Screening Market was valued at USD 388.16(Revenue in USD Billion) in 2022.
Asia-Pacific Newborn Screening Market is projected to grow at a CAGR of 14.70% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Newborn Screening Market for final year is USD 911.01 (USD Billion).
Asia-Pacific Newborn Screening Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Newborn Screening Market is segmented based on Segmentation Technology,Product Type,Test Type,End User,Disease Type.
Asia-Pacific Newborn Screening Market was valued at USD 388.16(Revenue in USD Billion) in 2022.
Asia-Pacific Newborn Screening Market is projected to grow at a CAGR of 14.70% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Newborn Screening Market for final year is USD 911.01 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.